EDITORIAL
Published on 03 Apr 2023
Editorial: Systemic immune dysregulation in malignant disease: Insights, monitoring and therapeutic exploitation
doi 10.3389/fonc.2023.1182081
- 810 views
- 1 citation
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Systemic immune dysregulation in malignant disease: insights, monitoring and therapeutic exploitation
Systemic immune dysregulation in malignant disease: insights, monitoring and therapeutic exploitation
21k
Total Downloads
70k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 08 Feb 2023
Characterization of the immune cell landscape in CRC: Clinical implications of tumour-infiltrating leukocytes in early- and late-stage CRC
doi 10.3389/fimmu.2022.978862
- 2,697 views
- 9 citations
ORIGINAL RESEARCH
Published on 07 Nov 2022
Human papillomavirus infection can alter the level of tumour stemness and T cell infiltration in patients with head and neck squamous cell carcinoma
doi 10.3389/fimmu.2022.1013542
- 1,612 views
- 4 citations
ORIGINAL RESEARCH
Published on 31 Oct 2022
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors
doi 10.3389/fonc.2022.1010660
- 2,012 views
- 11 citations
ORIGINAL RESEARCH
Published on 11 Oct 2022
The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer
doi 10.3389/fonc.2022.891511
- 1,997 views
- 11 citations
ORIGINAL RESEARCH
Published on 11 Aug 2022
Phenotypic and functional analysis of γδ T cells in the pathogenesis of human T-cell lymphotropic virus type 1 infection
doi 10.3389/fimmu.2022.920888
- 4,052 views
- 1 citation
ORIGINAL RESEARCH
Published on 22 Jul 2022
A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma
doi 10.3389/fimmu.2022.935595
- 1,697 views
- 7 citations
ORIGINAL RESEARCH
Published on 30 Jun 2022
Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods
doi 10.3389/fimmu.2022.862752
- 3,981 views
- 12 citations
REVIEW
Published on 02 Jun 2022
Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer
doi 10.3389/fimmu.2022.903562
- 14,880 views
- 14 citations
ORIGINAL RESEARCH
Published on 25 Jan 2022
Picturing of the Lung Tumor Cellular Composition by Multispectral Flow Cytometry
doi 10.3389/fimmu.2022.827719
- 6,315 views
- 6 citations
ORIGINAL RESEARCH
Published on 18 Jan 2022
Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer
doi 10.3389/fimmu.2021.754138
- 2,805 views
- 9 citations
ORIGINAL RESEARCH
Published on 03 Jan 2022
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization
doi 10.3389/fimmu.2021.798811
- 4,934 views
- 13 citations
Published in
Frontiers in Oncology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Impact
- 70kTopic views
- 47kArticle views
- 21kArticle downloads